Akamine Scott 4
4 · Cerevel Therapeutics Holdings, Inc. · Filed Feb 11, 2022
Insider Transaction Report
Form 4
Akamine Scott
Chief Legal Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-02-09+58,572→ 58,572 totalExercise: $30.36Exp: 2032-02-09→ Common Stock (58,572 underlying)
Footnotes (1)
- [F1]25% of this option shall vest and become exercisable on February 9, 2023, with the remainder vesting in thirty-six (36) monthly installments thereafter.